Total Payments
$11,644
2024 Payments
$2,269
Companies
24
Transactions
537
Medicare Patients
3,762
Medicare Billing
$319,279
Payment Breakdown by Category
Food & Beverage$11,298 (97.0%)
Education$346.39 (3.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,298 | 532 | 97.0% |
| Education | $346.39 | 5 | 3.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,097 | 112 | $0 (2024) |
| GENZYME CORPORATION | $1,528 | 47 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,204 | 72 | $0 (2024) |
| PFIZER INC. | $1,130 | 56 | $0 (2024) |
| Janssen Biotech, Inc. | $1,038 | 44 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $918.78 | 37 | $0 (2024) |
| Amgen Inc. | $904.89 | 31 | $0 (2024) |
| Lilly USA, LLC | $645.82 | 27 | $0 (2024) |
| UCB, Inc. | $525.15 | 34 | $0 (2024) |
| LEO Pharma Inc. | $366.99 | 23 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,269 | 102 | GENZYME CORPORATION ($304.29) |
| 2023 | $2,953 | 129 | ABBVIE INC. ($380.96) |
| 2022 | $3,240 | 141 | ABBVIE INC. ($727.13) |
| 2021 | $3,183 | 165 | AbbVie Inc. ($749.14) |
All Payment Transactions
537 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $38.52 | General |
| Category: Immunology | ||||||
| 12/18/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $33.49 | General |
| Category: DERMATOLOGY | ||||||
| 12/17/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $5.35 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: Dermatology | ||||||
| 12/12/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $19.23 | General |
| Category: Dermatology | ||||||
| 12/11/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $35.58 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/10/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $34.67 | General |
| Category: Inflammation | ||||||
| 12/05/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $25.01 | General |
| Category: Immunology | ||||||
| 12/05/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $4.64 | General |
| Category: Dermatology | ||||||
| 11/21/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $38.52 | General |
| Category: Immunology | ||||||
| 11/15/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $33.98 | General |
| Category: DERMATOLOGY | ||||||
| 11/14/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: Dermatology | ||||||
| 11/12/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $27.50 | General |
| Category: DERMATOLOGY | ||||||
| 11/08/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $4.43 | General |
| Category: Dermatology | ||||||
| 11/07/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $33.75 | General |
| Category: Immunology | ||||||
| 11/06/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $6.97 | General |
| Category: IMMUNOLOGY | ||||||
| 10/31/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $34.53 | General |
| Category: Immunology | ||||||
| 10/30/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $31.63 | General |
| Category: DERMATOLOGY | ||||||
| 10/29/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: DERMATOLOGY | ||||||
| 10/28/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $4.58 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/24/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $38.52 | General |
| Category: Immunology | ||||||
| 10/22/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $24.13 | General |
| Category: IMMUNOLOGY | ||||||
| 10/21/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $4.78 | General |
| Category: DERMATOLOGY | ||||||
| 10/18/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $19.23 | General |
| Category: Dermatology | ||||||
| 10/10/2024 | Lilly USA, LLC | OLUMIANT (Drug) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 2,224 | 6,003 | $613,313 | $191,719 |
| 2022 | 12 | 1,527 | 3,356 | $369,184 | $126,760 |
| 2021 | 1 | 11 | 11 | $2,915 | $799.60 |
Total Patients
3,762
Total Services
9,370
Medicare Billing
$319,279
Procedure Codes
26
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 606 | 1,093 | $174,921 | $57,857 | 33.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 387 | 630 | $92,379 | $26,631 | 28.8% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 187 | 258 | $56,047 | $19,443 | 34.7% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2023 | 34 | 60 | $32,900 | $18,390 | 55.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 286 | 286 | $75,514 | $17,790 | 23.6% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 337 | 3,097 | $56,812 | $13,632 | 24.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 166 | 191 | $44,922 | $12,383 | 27.6% |
| 96574 | Application of light with debridement to destroy precancer skin growth | Office | 2023 | 34 | 59 | $32,578 | $10,384 | 31.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 40 | 59 | $13,580 | $4,588 | 33.8% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 27 | 35 | $13,627 | $3,911 | 28.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 54 | 106 | $10,189 | $3,833 | 37.6% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 55 | 65 | $7,576 | $2,315 | 30.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 11 | 64 | $2,268 | $562.02 | 24.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 318 | 510 | $81,656 | $31,376 | 38.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 304 | 304 | $73,269 | $22,151 | 30.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 274 | 365 | $55,243 | $16,310 | 29.5% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 123 | 153 | $39,286 | $12,083 | 30.8% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2022 | 25 | 36 | $18,711 | $10,504 | 56.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 120 | 132 | $31,685 | $9,595 | 30.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 230 | 1,691 | $22,677 | $8,219 | 36.2% |
| 96574 | Application of light with debridement to destroy precancer skin growth | Office | 2022 | 25 | 35 | $19,386 | $7,276 | 37.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 40 | 52 | $12,067 | $4,590 | 38.0% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2022 | 19 | 20 | $8,220 | $2,498 | 30.4% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 32 | 37 | $4,958 | $1,364 | 27.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 17 | 21 | $2,025 | $795.80 | 39.3% |
About Sage Dow, CNP
Sage Dow, CNP is a Family healthcare provider based in Springfield, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/28/2017. The National Provider Identifier (NPI) number assigned to this provider is 1871009886.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Sage Dow, CNP has received a total of $11,644 in payments from pharmaceutical and medical device companies, with $2,269 received in 2024. These payments were reported across 537 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($11,298).
As a Medicare-enrolled provider, Dow has provided services to 3,762 Medicare beneficiaries, totaling 9,370 services with total Medicare billing of $319,279. Data is available for 3 years (2021–2023), covering 26 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Springfield, MA
- Active Since 12/28/2017
- Last Updated 10/23/2018
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1871009886
Products in Payments
- DUPIXENT (Biological) $2,340
- EUCRISA (Drug) $1,059
- RINVOQ (Biological) $1,015
- Otezla (Drug) $836.33
- TREMFYA (Drug) $834.08
- TALTZ (Drug) $613.55
- SKYRIZI (Biological) $572.82
- COSENTYX (Biological) $548.29
- COSENTYX (Drug) $489.79
- Cimzia (Drug) $483.47
- HUMIRA (Biological) $387.35
- OPZELURA (Drug) $263.65
- REMICADE (Biological) $203.87
- LIBTAYO (Biological) $194.14
- ADBRY (Biological) $191.49
- ENSTILAR (Drug) $175.50
- Sotyktu (Drug) $150.83
- VTAMA (Drug) $106.96
- SPEVIGO (Drug) $87.85
- IDACIO (Biological) $85.72
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Springfield
Mrs. Erin Duvall, Aprn, Fnp-C, Pmhnp-B, APRN, FNP-C, PMHNP-B
Family — Payments: $207,898
Family $207,898
Laura Hediger, Fnp, FNP
Family — Payments: $62,482
Family $62,482
Jenna Pelc, Np, NP
Family — Payments: $50,048
Family $50,048
Emily Wouk, Msn, Fpmhnp, Fnp, MSN, FPMHNP, FNP
Family — Payments: $41,104
Family $41,104
Mrs. Kristie Harrington, Fnp-Bc, FNP-BC
Family — Payments: $17,270
Family $17,270
Karen Smith, Crnp, CRNP
Family — Payments: $13,950
Family $13,950